Enabling value-based healthcare through automating risk assessment for episode-based care
通过对基于事件的护理进行自动化风险评估,实现基于价值的医疗保健
基本信息
- 批准号:9464424
- 负责人:
- 金额:$ 22.26万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-01 至 2018-08-31
- 项目状态:已结题
- 来源:
- 关键词:AttentionCardiacCaringChronicClinicClinicalClinical DataComplicationContinuity of Patient CareContractsCost ControlDataData CollectionData QualityData SetDiagnosisFoundationsGoalsHealth Care ReformHealthcareHealthcare SystemsHome environmentHospitalsHourInsuranceLabelMeasurementMeasuresMedicareModelingNatural Language ProcessingOntologyOutpatientsPatient-Focused OutcomesPatientsPhasePhenotypeProceduresProviderReplacement ArthroplastyResearchResourcesRiskRisk AdjustmentRisk AssessmentRunningSmall Business Innovation Research GrantTechnologyTestingTextTimeUnited StatesWorkbasecare episodeclinical careclinically relevantconcept mappingcostfeedingfinancial incentiveimprovedinterestoncologypaymentphysical therapistprogramssocialsuccessvector
项目摘要
Project Summary
Value-based healthcare implementation relies on understanding risk. 1 Early models, such as Medicare
Advantage, use annual measures of risk under a risk adjustment factor (RAF) to offer financial incentive
to payers and hospitals to work together. 2 More advanced models, such as bundled payments, target
the periods of greatest quality variability, specifically episodes of care such as joint replacement,
oncology diagnosis, and cardiac procedures. In these episodes, many types of providers, from hospitals
to outpatient physical therapists, need to work together to reduce rates of complication and
readmission. Risk levels are used to adjust payment for payer and providers and to determine which
patients require additional resources in the hospital, clinic, or home.
Unfortunately, existing risk models lack key features needed for episode-based care, which requires
both financial alignment and accurate and immediate information to adjust clinical resources for a given
case. 3 4 A better model would include all conditions relevant to an episode rather than just chronic
conditions, addition of social determinants, and an automated approach to retrieve the information in
hours rather than months. Thus, this Small Business Innovation Research (SBIR) Phase I program
includes the following Specific Aims:
1. Create the phenotyping components required to define an accurate and comprehensive model
of episode-based risk, including: (i) extract clinical and social features from clinical data using
natural language processing (NLP), (ii) map concepts including social features to an ontology
that will support normalized data use, (iii) build a feature vector for each record that can be
used to feed a risk model that accounts for relevant clinical and social risk
2. Validate the phenotyping components using de-identified longitudinal clinical data for 10,000
patients
In this research program, Phase I will tackle the most difficult challenges, including leveraging narrative
text to recognize time-labeled social and clinical features influencing an episode of care. Success criteria
will be accurate recognition of key underlying features that have not been available in risk models to
date. Phase II will build upon the validated technology to create an episode-based risk model run on
narrative and discrete clinical data and tested against actual patient outcomes. Success criteria will be a
validated episode-based risk model to support value-based contracting and value-based clinical care.
项目概要
基于价值的医疗保健实施依赖于对风险的理解。 1 早期模式,例如医疗保险
优点是,使用风险调整因子 (RAF) 下的年度风险衡量标准来提供财务激励
付款人和医院共同努力。 2 更先进的模式,如捆绑支付、目标
质量变化最大的时期,特别是关节置换等护理事件,
肿瘤学诊断和心脏手术。在这些事件中,来自医院的多种类型的提供者
对于门诊物理治疗师来说,需要共同努力降低并发症的发生率
重新入院。风险水平用于调整付款人和提供者的付款并确定哪些
患者需要医院、诊所或家中的额外资源。
不幸的是,现有的风险模型缺乏基于事件的护理所需的关键功能,这需要
财务调整和准确、即时的信息,以调整给定的临床资源
案件。 3 4 更好的模型应包括与发作相关的所有病症,而不仅仅是慢性病
条件、添加社会决定因素以及检索信息的自动化方法
几个小时而不是几个月。因此,这个小企业创新研究 (SBIR) 第一阶段计划
包括以下具体目标:
1. 创建定义准确且全面的模型所需的表型分析组件
基于事件的风险,包括:(i)使用以下方法从临床数据中提取临床和社会特征
自然语言处理 (NLP),(ii) 将包括社交特征在内的概念映射到本体
这将支持标准化数据使用,(iii)为每个记录构建一个特征向量,可以
用于构建考虑相关临床和社会风险的风险模型
2. 使用 10,000 例去识别的纵向临床数据验证表型成分
患者
在这个研究计划中,第一阶段将解决最困难的挑战,包括利用叙事
文本来识别影响护理事件的带有时间标记的社会和临床特征。成功标准
将准确识别风险模型中尚未提供的关键基本特征
日期。第二阶段将建立在经过验证的技术的基础上,创建一个基于事件的风险模型,运行在
叙述性和离散的临床数据,并根据实际患者的结果进行测试。成功的标准将是
验证基于事件的风险模型,以支持基于价值的合同和基于价值的临床护理。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Daniel Jay Riskin其他文献
Daniel Jay Riskin的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Daniel Jay Riskin', 18)}}的其他基金
Transforming Real-world evidence with Unstructured and Structured data to advance Tailored therapy (TRUST)
使用非结构化和结构化数据转换现实世界证据以推进定制治疗 (TRUST)
- 批准号:
10450726 - 财政年份:2020
- 资助金额:
$ 22.26万 - 项目类别:
Transforming Real-world evidence with Unstructured and Structured data to advance Tailored therapy (TRUST)
使用非结构化和结构化数据转换现实世界证据以推进定制治疗 (TRUST)
- 批准号:
10256676 - 财政年份:2020
- 资助金额:
$ 22.26万 - 项目类别:
Transforming Real-world evidence with Unstructured and Structured data to advance Tailored therapy (TRUST)
使用非结构化和结构化数据转换现实世界证据以推进定制治疗 (TRUST)
- 批准号:
10180783 - 财政年份:2020
- 资助金额:
$ 22.26万 - 项目类别:
Leveraging advanced clinical phenotyping to enhance problem lists and support value-based healthcare
利用先进的临床表型来增强问题清单并支持基于价值的医疗保健
- 批准号:
9762237 - 财政年份:2016
- 资助金额:
$ 22.26万 - 项目类别:
Subgroup Analytics and Advanced Semantic Technologies to Enable Personalized Medicine
亚组分析和先进语义技术可实现个性化医疗
- 批准号:
8979535 - 财政年份:2015
- 资助金额:
$ 22.26万 - 项目类别:
Voice Based, Workflow Enhancing, Primary Care Medical Data Input System
基于语音、增强工作流程的初级保健医疗数据输入系统
- 批准号:
7924457 - 财政年份:2010
- 资助金额:
$ 22.26万 - 项目类别:
相似海外基金
Examining the Function of a Novel Protein in the Cardiac Junctional Membrane Complex
检查心脏连接膜复合体中新型蛋白质的功能
- 批准号:
10749672 - 财政年份:2024
- 资助金额:
$ 22.26万 - 项目类别:
Targeting soluble guanylate cyclase as a novel strategy to treat and prevent cardiac arrhythmias: efficacy and mechanisms
靶向可溶性鸟苷酸环化酶作为治疗和预防心律失常的新策略:功效和机制
- 批准号:
MR/Y003594/1 - 财政年份:2024
- 资助金额:
$ 22.26万 - 项目类别:
Research Grant
Towards widespread use of cardiac MRI using new affordable low magnetic field (0.55T) MRI scanner and AI
使用新型经济实惠的低磁场 (0.55T) MRI 扫描仪和 AI 实现心脏 MRI 的广泛使用
- 批准号:
2904562 - 财政年份:2024
- 资助金额:
$ 22.26万 - 项目类别:
Studentship
Using Novel Machine Learning Methods to Personalize Strategies for Prevention of Persistent AKI after Cardiac Surgery
使用新颖的机器学习方法制定个性化策略,预防心脏手术后持续性 AKI
- 批准号:
10979324 - 财政年份:2024
- 资助金额:
$ 22.26万 - 项目类别:
Novel minimally-invasive in-situ 3D bioprinting platform for cardiac regeneration
用于心脏再生的新型微创原位3D生物打印平台
- 批准号:
EP/X027287/2 - 财政年份:2024
- 资助金额:
$ 22.26万 - 项目类别:
Fellowship
Investigating the mechanosensitive interplays between genetic control and self-organisation during the emergence of cardiac tissue curvature
研究心脏组织曲率出现过程中遗传控制和自组织之间的机械敏感性相互作用
- 批准号:
BB/Y00566X/1 - 财政年份:2024
- 资助金额:
$ 22.26万 - 项目类别:
Research Grant
Prevention of Infections in Cardiac Surgery (PICS): a cluster-randomized factorial cross-over trial
心脏手术中感染的预防 (PICS):整群随机因子交叉试验
- 批准号:
498291 - 财政年份:2023
- 资助金额:
$ 22.26万 - 项目类别:
Operating Grants
Postoperative reduction in thrombin generation in cardiac surgery: pathogenesis and evaluation
心脏手术术后凝血酶生成减少:发病机制和评估
- 批准号:
23H03001 - 财政年份:2023
- 资助金额:
$ 22.26万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of a novel therapy for cardiac fibrosis using a cell removal vaccine
使用细胞去除疫苗开发治疗心脏纤维化的新疗法
- 批准号:
23K07504 - 财政年份:2023
- 资助金额:
$ 22.26万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Aging of cardiac fibroblasts and heart failure: novel heart failure treatment through regeneration and transplantation of cardiac fibroblasts
心脏成纤维细胞的衰老和心力衰竭:通过心脏成纤维细胞的再生和移植治疗心力衰竭
- 批准号:
23K07526 - 财政年份:2023
- 资助金额:
$ 22.26万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




